Galilee Clinical Bio Research

Galilee Clinical Bio Research is a boutique CRO based in Israel, specializing in the management and execution of clinical trials for drugs, biologics, and medical devices. The company has managed complex multisite studies across Israel and the US, including Phase 4 oncology studies and early-phase cell therapy trials. It is currently involved as a sponsor or partner in a Phase 1 study evaluating umbilical cord-derived mesenchymal stromal cell therapy for systemic lupus erythematosus. The company leverages advanced digital platforms for real-time data collection and protocol compliance automation to accelerate study timelines[2][5].